The trajectory of companies tied to iconic drugs like Viagra presents a challenging investment scenario . While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the loss of exclusivity in key regions has introduced substantial risk . Investors are now facing the impact of generic competitio